NeuroBo Pharmaceuticals News, NeuroBo Pharmaceuticals Quote, NRBO Quote

NeuroBo Pharmaceuticals (NQ:NRBO) Delayed: 3.10 +0.08 (2.65%)

Prev. Close

$3.02

Open

$2.99

52 Wk High

$0.00

52 Wk Low

$0.00

Day High

$3.50

Day Low

$2.99

P/E

N/A

EPS

$0.00

Volume

39,360

Friends, Peers and Foes (?): REDS, CNVCF, BHSC, RVPH, BABYF (more...)

Apr 24, 2024 06:04 AM Form EFFECT NeuroBo Pharmaceuticals,
Apr 17, 2024 08:31 AM Form 8-K NeuroBo Pharmaceuticals, For: Apr 17
Apr 17, 2024 08:05 AM NeuroBo Pharmaceuticals Doses First Patient in Its Phase 1 Clinical Trial Evaluating DA-1726 for the Treatment of Obesity
Apr 16, 2024 04:31 PM Form 8-K NeuroBo Pharmaceuticals, For: Apr 16
Apr 12, 2024 04:08 PM NeuroBo Pharmaceuticals (NRBO) Files $150M Mixed Shelf
Apr 12, 2024 04:07 PM Form S-3 NeuroBo Pharmaceuticals,
Apr 1, 2024 08:30 AM Form 8-K NeuroBo Pharmaceuticals, For: Apr 01
Apr 1, 2024 08:08 AM NeuroBo Pharmaceuticals (NRBO) Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial of DA-1241
Apr 1, 2024 08:01 AM NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
Mar 28, 2024 04:19 PM Form 10-K NeuroBo Pharmaceuticals, For: Dec 31

Entities mentioned with NRBO